EKG

Cardiocomm Solutions Inc. (EKG)

Market Closed
11 Dec, 20:00
TSX-V TSX-V
CA$
0. 01
0
0%
CA$
- Market Cap
- P/E Ratio
0% Div Yield
58,000 Volume
0 Eps
CA$ 0.01
Previous Close
Day Range
0.01 0.01
Year Range
0.01 0.02
Want to track EKG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EKG closed Thursday higher at CA$0.01, an increase of 0% from Wednesday's close, completing a monthly increase of 0% or CA$0. Over the past 12 months, EKG stock gained 0%.
EKG is not paying dividends to its shareholders.
The last earnings report, released on Dec 01, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

EKG Chart

Cardiocomm Solutions Inc. (EKG) FAQ

What is the stock price today?

The current price is CA$0.01.

On which exchange is it traded?

Cardiocomm Solutions Inc. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is EKG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

Has Cardiocomm Solutions Inc. ever had a stock split?

No, there has never been a stock split.

Cardiocomm Solutions Inc. Profile

Insurance Industry
Financials Sector
Mr. Robert E. Caines CEO
TSX-V Exchange
CA14159N2086 ISIN
US Country
- Employees
- Last Dividend
26 Nov 2007 Last Split
- IPO Date

Overview

CardioComm Solutions, Inc. is a leading innovator in the field of cardiovascular technology, focusing on the development of sophisticated software and hardware products. Founded in 1989 and headquartered in Toronto, Canada, the company has made significant strides in advancing ECG and ambulatory arrhythmia monitoring systems for both medical and consumer markets across the globe. Beyond product development, CardioComm Solutions extends its expertise to core laboratory reading services, underlining its comprehensive approach to cardiac care and monitoring. Furthermore, the company plays a pivotal role in the sale of ECG recording equipment, catering to a wide range of healthcare needs.

Products and Services

  • Advanced Software Products

    CardioComm Solutions develops cutting-edge software designed to enhance the accuracy and efficiency of ECG and ambulatory arrhythmia monitoring. These software solutions facilitate real-time analysis, interpretation, and management of cardiac data, empowering healthcare professionals to deliver prompt and precise cardiac care.

  • Hardware Products for ECG and Ambulatory Arrhythmia Monitoring

    The company's hardware lineup includes state-of-the-art ECG recording devices and ambulatory arrhythmia monitoring systems. Engineered for both clinical and consumer usage, these devices ensure high fidelity recording and monitoring of cardiac activities, enabling early detection and intervention for arrhythmias and other cardiac conditions.

  • Core Laboratory Reading Services

    CardioComm Solutions offers specialized core laboratory reading services, providing expert ECG data analysis and interpretation. This service supports clinical trials and patient monitoring programs by ensuring data accuracy and reliability, critical for effective cardiac care and research.

  • ECG Recording Equipment Sales

    In addition to developing innovative cardiac monitoring solutions, CardioComm Solutions is actively involved in the sale of ECG recording equipment. This aspect of the business ensures that a wide array of healthcare providers have access to top-quality equipment necessary for comprehensive cardiac monitoring and diagnostics.

Contact Information

Address: 18 Wynford Drive, Toronto, ON, Canada, M3C 3S2
Phone: 416 977 9425